BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 13, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 2, 1997
View Archived Issues
Cytokine With Costimulator Doubled Tumor Regression; Human Trial Next Spring
Read More
Amylin Opts For $30M Loan From J&J For Pramlintide Trials
Read More
Matrix Restructures To Focus On Cancer; Lays Off 66 Staffers
Read More
Serono's Multiple Sclerosis Drug Strong In Phase III Studies
Read More
BioWorld Stock Report For Public Biotechnology Companies Part 2
Read More
Aradigm Signs Potential $40M Inhaler Deal With SmithKline
Read More
BioWorld Stock Report For Public Biotechnology Companies Part 1
Read More
Other News To Note
Read More
Cor Therapeutics Amends FDA Submission For Integrilin
Read More
